RCT | Safety and efficacy of zilucoplan in patients with generalized myasthenia gravis
11 May, 2023 | 12:04h | UTCSafety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study – The Lancet Neurology (link to abstract – $ for full-text)
News Release: Researchers report on rozanolixizumab, zilucoplan phase 3 myasthenia gravis study – MedicalXpress